PayPal’s board has rejected the $53 billion all-cash takeover offer from Stripe and Advent International as inadequate, concluding at a specially convened meeting that the $60.50-per-share bid fails to reflect the value management could deliver by finishing its turnaround. The market is reading this as an antitrust story. It is a price story. The remedy most often floated to satisfy competition authorities — divesting PayPal’s Braintree unit, which competes head-on with Stripe — would strip roughly 44% of PayPal’s payment volume but only about 8% of its gross profit, according to analyst estimates compiled in mid-July. A concession that cheap is not a deal-breaker. It is a rounding error the consortium can concede on day one.
The offer, submitted July 15, carried a premium of roughly 28% over PayPal’s undisturbed share price and would rank as the largest fintech acquisition ever attempted. Financing is not the obstacle either: the consortium has assembled a package of about $50 billion arranged by JPMorgan and Morgan Stanley, with roughly $17 billion in equity split evenly between Stripe and Advent, PYMNTS reported. Combined, the two businesses would process an estimated $3.7 trillion in annual payment volume — Stripe at $1.9 trillion in 2025, growing 34% year on year, against PayPal’s $1.8 trillion and 439 million active accounts.
That scale is precisely what invites scrutiny. Analysts across several firms put the combined entity near 65% of global online payment volume, a concentration that would draw parallel reviews from the Federal Trade Commission, the Department of Justice and European competition authorities. But look at where the proposed remedy sends the divested asset. Advent’s payments portfolio already contains Nuvei — currently installing a new COO, CFO and CPTO ahead of closing its Payoneer deal — and previously included Worldpay. Moving Braintree into that portfolio does not restore competition at the merchant-acquiring layer. It consolidates it one level down, under a single private-equity sponsor, while satisfying the letter of the remedy.
Sell-side analysts anticipated the rebuff almost to the day. “We do not think PayPal’s new CEO will likely embrace what could be viewed as a low-ball offer. If the current offer is an opening salvo, we could see Stripe and Advent go as high as $70 per share,” wrote Andrew Jeffrey, senior analyst at William Blair, in a July 16 research note. A move to $70 would lift the equity cheque to roughly $61 billion — material, but well inside what a consortium already committing $17 billion of equity can stretch to if the strategic logic holds.
PayPal’s negotiating position is weaker than the rejection implies. The company replaced chief executive Alex Chriss in February 2026 after the board judged that turnaround execution was falling short, leaving a new management team asking shareholders to believe in a plan that the previous board had already lost patience with. Rejecting a 28% premium on that basis is a defensible opening move, but it is an argument that gets harder to make each quarter the turnaround underdelivers. Directors are also, per the board’s own review, watching for competing bids — and no rival has surfaced.
The wider context is a payments sector consolidating at both ends. Mastercard is exploring a majority sale of Vocalink at a £400 million valuation, while distribution deals such as Lloyds and Stripe’s tie-up for UK small businesses show acquirers buying reach rather than building it. Stripe’s interest in PayPal follows the same logic: it is buying 439 million funded consumer accounts and a wallet, not merchant processing it already dominates.
Expect a revised bid rather than a walk-away. The consortium’s financing is committed, the antitrust remedy is cheap, and the target’s board has explicitly left the door open by framing its objection around price rather than principle — the language of a negotiation, not a refusal. The number to watch is $70 per share, Jeffrey’s stated ceiling. If Stripe and Advent return below $65, PayPal’s board can credibly hold out again; at $70 the turnaround argument stops being a defence and starts being a bet the directors would have to justify to shareholders line by line. Our earlier coverage of the original $53bn approach set out the strategic case; the rejection has not changed it, only its price.
Rick Steves
Rick Steves has seen business and economics through many lenses. He joined the financial services industry in 2009, and has been a financial journalist since 2011. He holds a degree in Business Administration and has experience producing real-time news, from both buy-side and sell-side, as well as for retail traders, brokers and service providers. Steves' work has appeared in a variety of online publications including FX Street, NewsBTC, FinanceFeeds, and The Industry Spread. Rick has great interest in the dynamics of the trading industry. The never-ending clash between technology, economics, regulation, and more importantly, the people.
